Carella, A M <br/><br/>
Interferon-alpha is able to maintain complete molecular remission induced by imatinib after its discontinuation.  [electronic resource] 

 -  Leukemia  May 2008 
 - 1090-1 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/leu.2008.94  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Benzamides<br/>Female<br/>Humans<br/>Imatinib Mesylate<br/>Interferon-alpha--therapeutic use<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Male<br/>Piperazines--therapeutic use<br/>Pyrimidines--therapeutic use<br/>Remission Induction